Core Viewpoint - China CRRC has accelerated its operational performance, achieving record highs in both revenue and net profit for 2025, with significant growth in new industries and international markets [1][4][5]. Financial Performance - In 2025, China CRRC reported revenue of 273.06 billion yuan, a year-on-year increase of 10.79%, and a net profit attributable to shareholders of 13.18 billion yuan, up 6.40% [1][4]. - The company achieved a record high in both revenue and net profit, with the revenue growth rate reaching double digits, the highest since 2015 [4][5]. - The net profit growth rate was the fastest in three years, with previous years showing lower growth rates [4][5]. Market Expansion - Revenue from markets outside mainland China reached 34.82 billion yuan, growing by 22.88% year-on-year, accounting for 12.75% of total revenue [5][6]. - The new industry segment generated revenue of 103.12 billion yuan, marking a 19.39% increase and surpassing the 100 billion yuan mark for the first time [5][6]. R&D and Innovation - In 2025, the company invested approximately 18.16 billion yuan in R&D, representing 6.65% of its revenue, with a total of 5,581 new patent applications filed [2][10][11]. - The number of R&D personnel reached 23,300, making up 15.39% of the total workforce, indicating a strong focus on technological innovation [11][12]. Order Backlog - By the end of 2025, the company had a backlog of orders amounting to 357.1 billion yuan, reflecting a 12.26% increase from the previous year [9][12]. - The growth in new orders, particularly in international markets, underscores the company's competitive position globally [9][12].